`BIB_179`

Larkin J et al. Vemurafenib + Cobimetinib (coBRIM). NEJM 2014;371(20):1867–1876. PMID 25265492. PFS ~12 months; ORR ~70%. Photosensitivity + dermatologic toxicity. [Tasks: 18] Tier: 1 Grade: A Retrieved: 2026-05-07

Evidence grade: A
Tier: 1
Cited by tasks: 18
Identifiers: PMID:25265492

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_179/findings.md (research corpus). This page is a short context summary — not individualised medical advice.